Close Menu

NEW YORK — DiamiR said on Thursday that it has been awarded nearly $3.9 million in grant funding from the National Institutes of Health to support the development of the company's microRNA diagnostics for mild cognitive impairment (MCI), Alzheimer's disease, and the rare neurological disorder Rett syndrome.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.